SLC2A1 and laryngeal carcinoma: In a previous study, we confirmed that CRISPR/CAS9‐mediated Glut‐1 and HIF‐1α double knockout robustly reduced the proliferation, migration and invasion of laryngeal carcinoma HEp‐2 cells, possibly by modulating the PI3K/Akt signalling pathway.23